{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:41Z","timestamp":1789148981877,"version":"build-2803163510"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11739-025-03874-x","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T19:51:48Z","timestamp":1738007508000},"page":"1293-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting Janus kinase 1 in refractory Beh\u00e7et\u2019s disease: a case report on the clinical efficacy of upadacitinib"],"prefix":"10.1007","volume":"20","author":[{"given":"Claudia","family":"Ammoscato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-9566","authenticated-orcid":false,"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"1","key":"3874_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13688","volume":"17","author":"MF Mohamed","year":"2024","unstructured":"Mohamed MF, Bhatnagar S, Parmentier JM, Nakasato P, Wung P (2024) Upadacitinib: mechanism of action, clinical, and translational science. Clin Transl Sci 17(1):e13688. https:\/\/doi.org\/10.1111\/cts.13688","journal-title":"Clin Transl Sci"},{"issue":"7","key":"3874_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMra2305712","volume":"390","author":"D Saadoun","year":"2024","unstructured":"Saadoun D, Bodaghi B, Cacoub P (2024) Beh\u00e7et\u2019s syndrome. Ingelfinger, ed. N Engl J Med 390(7):640\u2013651. https:\/\/doi.org\/10.1056\/NEJMra2305712","journal-title":"N Engl J Med"},{"issue":"01","key":"3874_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0028-1103481","volume":"41","author":"S Lee","year":"2009","unstructured":"Lee S, Kim B, Kim T, Kim W (2009) Differential diagnosis of intestinal Beh\u00e7et\u2019s disease and Crohn\u2019s disease by colonoscopic findings. Endoscopy 41(01):9\u201316. https:\/\/doi.org\/10.1055\/s-0028-1103481","journal-title":"Endoscopy"},{"issue":"2","key":"3874_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/gene.2014.64","volume":"16","author":"A Tulunay","year":"2015","unstructured":"Tulunay A, Dozmorov MG, Ture-Ozdemir F et al (2015) Activation of the JAK\/STAT pathway in Behcet\u2019s disease. Genes Immun 16(2):170\u2013175. https:\/\/doi.org\/10.1038\/gene.2014.64","journal-title":"Genes Immun"},{"issue":"11","key":"3874_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/annrheumdis-2020-217307","volume":"79","author":"J Liu","year":"2020","unstructured":"Liu J, Hou Y, Sun L et al (2020) A pilot study of tofacitinib for refractory Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 79(11):1517\u20131520. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217307","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3874_CR6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1080\/09273948.2023.2263557","volume":"32","author":"T Tao","year":"2024","unstructured":"Tao T, He D, Peng X, Huang Z, Su W (2024) Successful remission with upadacitinib in two patients with anti-TNF-refractory macular edema associated with Beh\u00e7et\u2019s uveitis. Ocul Immunol Inflamm 32(8):1897\u20131900. https:\/\/doi.org\/10.1080\/09273948.2023.2263557","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-03874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-03874-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-03874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:04:23Z","timestamp":1748865863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-025-03874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3874"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-03874-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FI and GL received speaker honoraria from Abbvie. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study does not contain any studies with animals performed by any of the authors and complies with the guidelines for human studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"The patient provided written informed consent for the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}